Eric Flenaugh, MD
Pulmonary Disease · Atlanta, GANPI 1689674566
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (33.4%), consulting fees and speaking fees — rather than concentrated in one kind of arrangement. 37 manufacturers reported payments, led by Veran Medical Technologies, Inc. at 41.3% of the total. Reporting peaked in 2019 at $33,206 and has fallen 58.5% since, to $13,776 in 2025. Among pulmonary disease clinicians in GA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 363 payments — averaging $255.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Veran Medical Technologies, Inc.$38K
- Olympus America Inc.$20K
- Cook Medical LLC$7K
- Olympus Medical Systems Corporation$4K
- Cook Incorporated$4K
- AstraZeneca$3K
- plus $17K from 31 others
Across 4 payments — averaging $1169.20 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Amgen$5K
What the payments were for
- Consulting fees$29,47032%
- Speaking & faculty fees$22,40024%
- Travel & lodging$30,97633%
- Food & beverage$9,86011%
- Education$170%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Veran Medical Technologies, Inc. | 58 | $38,315 |
| Olympus America Inc. | 35 | $19,685 |
| Cook Medical LLC | 4 | $6,524 |
| Olympus Medical Systems Corporation | 3 | $4,380 |
| Cook Incorporated | 1 | $4,050 |
| AstraZeneca | 7 | $2,671 |
| Medtronic | 15 | $2,410 |
| Pinnacle Biologics, Inc | 10 | $2,056 |
| Johnson & Johnson(3 entities) | 62 | $1,993 |
| Intuitive Surgical | 13 | $1,962 |
| Olympus Corporation | 6 | $1,468 |
| Noah Medical Corporation | 5 | $1,187 |
| Olympus Corporation Of The Americas | 12 | $1,186 |
| Amgen | 2 | $981 |
| Pfizer | 54 | $928 |
| AbbVie(2 entities) | 27 | $537 |
| Elucent Medical | 1 | $450 |
| Gyrus ACMI, Inc. | 1 | $365 |
| Tempus AI, Inc | 9 | $237 |
| Actelion Pharmaceuticals US, Inc. | 8 | $174 |
| Vapotherm Inc | 2 | $155 |
| Regeneron Healthcare Solutions, Inc. | 2 | $133 |
| Sanofi | 1 | $124 |
| United Therapeutics Corporation | 1 | $122 |
| Inspire Medical Systems, Inc. | 3 | $116 |
| Boston Scientific | 1 | $93 |
| Merck | 4 | $90 |
| Insmed, Inc. | 3 | $77 |
| Shionogi Inc | 3 | $60 |
| Melinta Therapeutics, LLC | 2 | $50 |
| Vertex | 1 | $25 |
| GSK | 2 | $25 |
| Daiichi Sankyo Inc. | 1 | $24 |
| Pulmonx Corporation | 1 | $20 |
| Electromed, Inc. | 1 | $18 |
| Medical Device Business Services, Inc. | 1 | $18 |
| Ambu Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Spin$34,177
- SPiN Thoracic Navigation System, 120V, 60Hz$10,320
- Always-On Tip Tracked Forceps, 1.8mm OD, Serrated Cup$10,220
- SPiN Perc Localization Needle 19ga x 105mm, 1cm marking zone$10,220
- EVES EUS ULTRASOUND BRONCHOFIBERVIDEOSCOPE$8,025
- Cook Medical Critical Care$6,130
- Blue Rhino$4,050
- EVIS EXERA II ULTRASONIC BRONCHOFIBERVIDEOSCOPE$2,555
- ILLUMISITE$2,080
- Da Vinci Surgical System$1,740
- Photofrin$1,727
- XARELTO$710
- Cook Medical Percutaneous Tracheostomy$313
- Monarch Platform$303
- DUPIXENT$247
- Spiration Valve System$147
- VAPOTHERM$125
- LIBTAYO$116
How this compares
$92,724 in reported general payments places this provider in the 95th percentile of 365 pulmonary disease providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 32 | $21,418 |
| Incruse ElliptaUmeclidinium Bromide | 11 | $3,499 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 46 | $1,439 |
| Ventolin HfaAlbuterol Sulfate | 13 | $602 |
| Montelukast Sodium | 13 | $119 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta, Incruse Ellipta | $25 | $24,91743 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 365 pulmonary disease providers in Georgia.
Other pulmonary disease in Atlanta
- Colin SwensonAtlanta$255K
- Gregory MartinAtlanta$88K
- Victor TsengAtlanta$55K
- Ralitza MartinAtlanta$48K
- Venkatesh LakshminarayananAtlanta$33K
- Sisir AkkineniAtlanta$21K
- Gerald StatonAtlanta$21K
- Mirza AliAtlanta$16K
- Srihari VeeraraghavanAtlanta$16K
- Lawrence McDermottSavannah$963K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.